FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967355800> ?p ?o ?g. }

• W2967355800 endingPage "1522" @default.
• W2967355800 startingPage "1514" @default.
• W2967355800 abstract "Abstract Background In this prospective study (NCT03443609), we investigated the impact of 68Ga‐PSMA‐11 PET‐CT on the treatment plan and therapeutic response obtained for patients with prostate cancer (PCa) presenting a recurrence with a low rising PSA. Methods One hundred thirty hormone‐naive (PSA < 1.5 ng/mL) patients were enrolled. All patients received radical treatment. PET images were recorded 1 and 2 hours after injection of tracer and interpreted by two independent nuclear physicians. Six months after treatment ended, a PSA assay was requested to evaluate the therapeutic efficacy of the treatment based on PSMA results. Results Data analysis for the first 52 included patients has been completed. 68Ga‐PSMA‐11–positive lesions were detected in 38/52 (73.1%) patients. Ninety‐four lesions were detected as follows, 53/94 in lymph nodes (56.4%), 25/94 in bone (26.6%), and 12/94 into the prostate bed (12.7%). Detection rates were 58%, 81%, and 82% for serum PSA levels lower than 0.25 ng/mL, between 0.25 to ≤ 0.69 ng/mL and 0.70 ng/mL, respectively. As a result of the PSMA PET‐CT, therapeutic management changed in 38/52 patients (73.1%). Patients had undetectable serum PSA levels after treatment guided by 68Ga‐PSMA‐11 PET‐CT results in 10/52 (19.2%) cases and with a PSA decrease of over 60% in 18/52 (34.6%) patients. Conclusion Whilst our patient population presented a very low PSA level, preliminary results of the 68Ga‐PSMA PET‐CT study showed recurrence localization in more than half of the patients and this had a major clinical impact, as it resulted in treatment change in more than half of the patients and a significant decrease in PSA levels in a third of patients." @default.
• W2967355800 created "2019-08-22" @default.
• W2967355800 creator A5001022411 @default.
• W2967355800 creator A5013375868 @default.
• W2967355800 creator A5021513670 @default.
• W2967355800 creator A5022695085 @default.
• W2967355800 creator A5026351466 @default.
• W2967355800 creator A5029833287 @default.
• W2967355800 creator A5029972934 @default.
• W2967355800 creator A5032958001 @default.
• W2967355800 creator A5041526466 @default.
• W2967355800 creator A5047157770 @default.
• W2967355800 creator A5062137018 @default.
• W2967355800 creator A5067155189 @default.
• W2967355800 creator A5071588217 @default.
• W2967355800 creator A5077470196 @default.
• W2967355800 creator A5087199834 @default.
• W2967355800 date "2019-08-17" @default.
• W2967355800 modified "2023-10-18" @default.
• W2967355800 title "Preliminary results of a ⁶⁸Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making" @default.
• W2967355800 cites W1903999661 @default.
• W2967355800 cites W1978337671 @default.
• W2967355800 cites W2043601120 @default.
• W2967355800 cites W2137670219 @default.
• W2967355800 cites W2179945673 @default.
• W2967355800 cites W2211198407 @default.
• W2967355800 cites W2257635864 @default.
• W2967355800 cites W2317795708 @default.
• W2967355800 cites W2415076046 @default.
• W2967355800 cites W2470255787 @default.
• W2967355800 cites W2504111721 @default.
• W2967355800 cites W2511949746 @default.
• W2967355800 cites W2540348172 @default.
• W2967355800 cites W2561039633 @default.
• W2967355800 cites W2589983641 @default.
• W2967355800 cites W2591849683 @default.
• W2967355800 cites W2598457068 @default.
• W2967355800 cites W2766371188 @default.
• W2967355800 cites W2774325924 @default.
• W2967355800 cites W2790611423 @default.
• W2967355800 cites W2808437932 @default.
• W2967355800 cites W2886449856 @default.
• W2967355800 doi "https://doi.org/10.1002/pros.23869" @default.
• W2967355800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31421657" @default.
• W2967355800 hasPublicationYear "2019" @default.
• W2967355800 type Work @default.
• W2967355800 sameAs 2967355800 @default.
• W2967355800 citedByCount "17" @default.
• W2967355800 countsByYear W29673558002020 @default.
• W2967355800 countsByYear W29673558002021 @default.
• W2967355800 countsByYear W29673558002022 @default.
• W2967355800 countsByYear W29673558002023 @default.
• W2967355800 crossrefType "journal-article" @default.
• W2967355800 hasAuthorship W2967355800A5001022411 @default.
• W2967355800 hasAuthorship W2967355800A5013375868 @default.
• W2967355800 hasAuthorship W2967355800A5021513670 @default.
• W2967355800 hasAuthorship W2967355800A5022695085 @default.
• W2967355800 hasAuthorship W2967355800A5026351466 @default.
• W2967355800 hasAuthorship W2967355800A5029833287 @default.
• W2967355800 hasAuthorship W2967355800A5029972934 @default.
• W2967355800 hasAuthorship W2967355800A5032958001 @default.
• W2967355800 hasAuthorship W2967355800A5041526466 @default.
• W2967355800 hasAuthorship W2967355800A5047157770 @default.
• W2967355800 hasAuthorship W2967355800A5062137018 @default.
• W2967355800 hasAuthorship W2967355800A5067155189 @default.
• W2967355800 hasAuthorship W2967355800A5071588217 @default.
• W2967355800 hasAuthorship W2967355800A5077470196 @default.
• W2967355800 hasAuthorship W2967355800A5087199834 @default.
• W2967355800 hasBestOaLocation W29673558002 @default.
• W2967355800 hasConcept C121608353 @default.
• W2967355800 hasConcept C126322002 @default.
• W2967355800 hasConcept C126838900 @default.
• W2967355800 hasConcept C126894567 @default.
• W2967355800 hasConcept C142724271 @default.
• W2967355800 hasConcept C188816634 @default.
• W2967355800 hasConcept C204787440 @default.
• W2967355800 hasConcept C2776235491 @default.
• W2967355800 hasConcept C2779466945 @default.
• W2967355800 hasConcept C2780192828 @default.
• W2967355800 hasConcept C2908647359 @default.
• W2967355800 hasConcept C2989005 @default.
• W2967355800 hasConcept C520017518 @default.
• W2967355800 hasConcept C71924100 @default.
• W2967355800 hasConcept C99454951 @default.
• W2967355800 hasConceptScore W2967355800C121608353 @default.
• W2967355800 hasConceptScore W2967355800C126322002 @default.
• W2967355800 hasConceptScore W2967355800C126838900 @default.
• W2967355800 hasConceptScore W2967355800C126894567 @default.
• W2967355800 hasConceptScore W2967355800C142724271 @default.
• W2967355800 hasConceptScore W2967355800C188816634 @default.
• W2967355800 hasConceptScore W2967355800C204787440 @default.
• W2967355800 hasConceptScore W2967355800C2776235491 @default.
• W2967355800 hasConceptScore W2967355800C2779466945 @default.
• W2967355800 hasConceptScore W2967355800C2780192828 @default.
• W2967355800 hasConceptScore W2967355800C2908647359 @default.
• W2967355800 hasConceptScore W2967355800C2989005 @default.
• W2967355800 hasConceptScore W2967355800C520017518 @default.
• W2967355800 hasConceptScore W2967355800C71924100 @default.

• next